Detalles de la búsqueda
1.
Enablers and inhibitors of the implementation of the Casalud Model, a Mexican innovative healthcare model for non-communicable disease prevention and control.
Health Res Policy Syst
; 14(1): 52, 2016 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443309
2.
Gestational Diabetes Mellitus Subtypes Classified by Oral Glucose Tolerance Test and Maternal and Perinatal Outcomes: Results of a Mexican Multicenter Prospective Cohort Study "Cuido Mi Embarazo".
Diabetes Metab Syndr Obes
; 17: 1491-1502, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38559615
3.
MIDO GDM: an innovative artificial intelligence-based prediction model for the development of gestational diabetes in Mexican women.
Sci Rep
; 13(1): 6992, 2023 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37117235
4.
Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational Diabetes.
Diabetes Metab Syndr Obes
; 15: 3855-3870, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36540348
5.
Integrated Measurement for Early Detection (MIDO) as a digital strategy for timely assessment of non-communicable disease profiles and factors associated with unawareness and control: a retrospective observational study in primary healthcare facilities in Mexico.
BMJ Open
; 11(9): e049836, 2021 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34475175
6.
Supply-side interventions to improve health: Findings from the Salud Mesoamérica Initiative.
PLoS One
; 13(4): e0195292, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659586
7.
Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model.
Diabetes Metab Syndr Obes
; 10: 443-455, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089779
8.
A Policy Analysis on the Proactive Prevention of Chronic Disease: Learnings from the Initial Implementation of Integrated Measurement for Early Detection (MIDO).
Int J Health Policy Manag
; 6(6): 339-344, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28812826
Resultados
1 -
8
de 8
1
Próxima >
>>